Emile Daoud, MD, Associate Editor of JACC: Clinical Electrophysiology discusses a recently published original research paper on the Safety and Feasibility of Pulsed Field Ablation in Patients with Mechanical Prosthetic Valves

Mirza Umair Khalid, MD, social media editor of JACC: Cardiovascular Interventions, and Thomas J. Stocker, MD, discuss a recently published original research paper reporting the long-term outcomes after mitral transcatheter edge-to-edge repair for secondary mitral regurgitation.

JACC: Case Reports Associate Editor Maurizio Taramasso, MD, PhD, joins author Brinder S Kanda, MD, FACC to discuss their case presented at AHA and published in JACC: Case Reports. In this case, an 83-year-old female with decompensated heart failure was found to have HOCM with SAM of the mitral valve and a large P2 flail segment with ruptured cords. TEER was performed resulting in mild MR and resolution of the prior LVOT gradient. The case supports TEER for patients with medication-refractory HOCM.

What is the current state of evidence behind the use of traditional Chinese medicine in the treatment of cardiovascular disease? Dr. Iokfai Cheang sheds light on this topic through both a clinical and research lens as we discuss the Luobing theory of traditional Chinese medicine.

Dr. Danyan Xu is a chief physician, professor, and the director of the Cardiac Rehabilitation Unit of the Department of Cardiovascular Medicine of the Second Xiangya Hospital, Central South University. She shares insights into cardiac rehabilitation. Moderated by Dr. Zhangling Chen.

Novi Yanti Sari, MD, social media editor of JACC: Heart Failure, discusses a recently published original research paper that explored new ways to manage hyperkalemia in patients with HFrEF.

Nikhil Narang, MD, social media editor of JACC: Heart Failure, discusses a recently published original research paper on the clinical trajectory of patients with advanced ambulatory heart failure in the REVIVAL trial.

JACC Heart Failure Associate Editor Sean Pinney, MD, discusses a recently published original research paper that explores the results of a randomized controlled trial to test whether evolocumab reduces the burden of cardiac allograft vasculopathy.